Equifax (NYSE:EFX) had its target price upped by stock analysts at Morgan Stanley from $112.00 to $119.00 in a report issued on Wednesday. The brokerage currently has an “equal weight” rating on the credit services provider’s stock. Morgan Stanley’s price objective suggests a potential downside of 4.88% from the company’s current price.
A number of other research firms also recently issued reports on EFX. Zacks Investment Research upgraded shares of Equifax from a “sell” rating to a “hold” rating in a research report on Tuesday, January 16th. Royal Bank of Canada lifted their price target on shares of Equifax to $126.00 and gave the company a “sector perform” rating in a research report on Friday, January 19th. Robert W. Baird reiterated a “buy” rating and set a $137.00 price target on shares of Equifax in a research report on Tuesday, January 9th. Barclays downgraded shares of Equifax from an “overweight” rating to an “equal weight” rating and lifted their price target for the company from $115.00 to $128.00 in a research report on Thursday, December 14th. Finally, Wells Fargo & Co set a $127.00 price target on shares of Equifax and gave the company a “buy” rating in a research report on Friday, October 6th. Nine analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Equifax presently has a consensus rating of “Hold” and a consensus price target of $128.07.
Shares of Equifax (NYSE EFX) traded up $2.03 during trading hours on Wednesday, reaching $125.11. 219,084 shares of the company were exchanged, compared to its average volume of 1,168,972. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.67 and a current ratio of 0.67. The firm has a market capitalization of $14,982.31, a P/E ratio of 28.38, a P/E/G ratio of 2.13 and a beta of 0.95. Equifax has a 1 year low of $89.59 and a 1 year high of $147.02.
Institutional investors and hedge funds have recently modified their holdings of the company. ETF Managers Group LLC purchased a new position in shares of Equifax during the 2nd quarter worth approximately $137,000. Benjamin F. Edwards & Company Inc. purchased a new position in shares of Equifax during the 4th quarter worth approximately $101,000. Sun Life Financial INC increased its stake in shares of Equifax by 9,722.2% during the 2nd quarter. Sun Life Financial INC now owns 884 shares of the credit services provider’s stock worth $121,000 after purchasing an additional 875 shares in the last quarter. Valeo Financial Advisors LLC purchased a new position in shares of Equifax during the 3rd quarter worth approximately $130,000. Finally, Meeder Asset Management Inc. purchased a new position in shares of Equifax during the 3rd quarter worth approximately $134,000. 94.94% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: “Equifax (EFX) Given New $119.00 Price Target at Morgan Stanley” was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://sportsperspectives.com/2018/01/31/equifax-efx-given-new-119-00-price-target-at-morgan-stanley.html.
Equifax Inc is a global provider of information solutions and human resources business process outsourcing services for businesses, governments and consumers. The Company operates in four segments: U.S. Information Solutions (USIS), International, Workforce Solutions and Global Consumer Solutions. Its products and services are based on databases of consumer and business information derived from various sources, including credit, financial assets, telecommunications and utility payments, employment, income, demographic and marketing data.
Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.